<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-217-9-125-130</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2455</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Выбор оптимальной концентрации декстрана сульфата натрия для воспроизведения химически индуцированного колита у кроликов</article-title><trans-title-group xml:lang="en"><trans-title>Choosing the optimal concentration of dextran sulfate sodium for reproducing chemically induced colitis in rabbits</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4418-4601</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Решетников</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Reshetnikov</surname><given-names>M. N.</given-names></name></name-alternatives><email xlink:type="simple">taxol@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5234-349X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Виноградова</surname><given-names>Т. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vinogradova</surname><given-names>T. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2814-4826</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зюзя</surname><given-names>Ю. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Zyuzya</surname><given-names>Yu. R.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6659-7888</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плоткин</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Plotkin</surname><given-names>D. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8374-191X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волков</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Volkov</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9161-466X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Догонадзе</surname><given-names>М. З.</given-names></name><name name-style="western" xml:lang="en"><surname>Dogonadze</surname><given-names>M. Z.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2946-2415</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Заболотных</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zabolotnykh</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4552-5022</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богородская</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogorodskaya</surname><given-names>E. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4385-9643</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яблонский</surname><given-names>П. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Yablonsky</surname><given-names>P. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Московский городской научно-практический центр борьбы с туберкулёзом Департамента здравоохранения г. Москвы»; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Research and Clinical Center for TB Control Moscow Healthcare Department; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГБУЗ «Московский городской научно-практический центр борьбы с туберкулёзом Департамента здравоохранения г. Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Research and Clinical Center for TB Control Moscow Healthcare Department</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ГБУЗ «Московский городской научно-практический центр борьбы с туберкулёзом Департамента здравоохранения г. Москвы»; ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н. И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Research and Clinical Center for TB Control Moscow Healthcare Department; Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>17</day><month>01</month><year>2024</year></pub-date><volume>0</volume><issue>9</issue><fpage>125</fpage><lpage>130</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Решетников М.Н., Виноградова Т.И., Зюзя Ю.Р., Плоткин Д.В., Волков А.А., Догонадзе М.З., Заболотных Н.В., Богородская Е.М., Яблонский П.К., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Решетников М.Н., Виноградова Т.И., Зюзя Ю.Р., Плоткин Д.В., Волков А.А., Догонадзе М.З., Заболотных Н.В., Богородская Е.М., Яблонский П.К.</copyright-holder><copyright-holder xml:lang="en">Reshetnikov M.N., Vinogradova T.I., Zyuzya Y.R., Plotkin D.V., Volkov A.A., Dogonadze M.Z., Zabolotnykh N.V., Bogorodskaya E.M., Yablonsky P.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2455">https://www.nogr.org/jour/article/view/2455</self-uri><abstract><p>Обоснование. Воспалительные заболевания (ВЗК) кишечника широко распространены в популяции, в этой связи, разработка новых лекарственных средств для лечения ВЗК является приоритетной задачей здравоохранения. Доклинические испытание лекарственных препаратов неразрывно связаны с моделированием ВЗК на лабораторных животных. Целью настоящего исследования явилась разработка модели химически индуцированного колита у кроликов. Методы. Исследование выполнено на кроликах-самцах породы «Советская шиншилла». Моделирование колита осуществлялось пероральным введением декстрана сульфата натрия (DSS) в концентрации от 0,1% до 2% раствора в течение пяти последовательных дней. Эвтаназия лабораторных животных проводилась на седьмой день, после окончания приема раствора DSS. Проводили гистологическое исследование кишечника. Результаты. Обнаружено, что при использовании 0,1% раствора DSS удалось получить модель эрозивного колита легкой степени. Эрозивно-язвенный колит средне-тяжелой степени получен при использовании 0,5% раствора DSS. Использование концентрации DSS более 1% привело к развитию у кроликов язвенного колита тяжелой степени, что привело к гибели 71,4% животных. Заключение. Полученные результаты свидетельствуют, что применение 0,5% раствора DSS позволят получить модель эрозивно-язвенного колита у кроликов, подходящую для изучения ВЗК человека.</p></abstract><trans-abstract xml:lang="en"><p>Background. Due to the fact that inflammatory bowel diseases (IBD) are widespread among the population, the development of new drugs for the treatment of IBD is a public health priority. Preclinical drug testing is inextricably linked with the modeling of IBD in laboratory animals. This study purpose was to develop a model of chemically induced colitis in rabbits. Methods. The study was performed on male rabbits of the “Soviet Chinchilla” breed. Colitis was simulated by oral administration of dextran sulfate sodium (DSS) in a concentration of 0.1% to 2% solution for five consecutive days. Euthanasia of laboratory animals was carried out on the seventh day, after the end of taking the DSS solution. A histological examination of the intestine was performed. Results. It was found that using 0.1% DSS solution allows to obtain a model of mild erosive colitis. The use of 0.5% DSS solution gave the intermediate severity of erosive ulcerative colitis. DSS concentration of more than 1% led to the development of severe ulcerative colitis in rabbits and the death rate of 71.4% among them. Conclusion. The obtained results indicate that the use of 0.5% DSS solution makes it possible to create a model of erosive ulcerative colitis in rabbits suitable for studying human IBD.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>болезнь Крона</kwd><kwd>язвенный колит</kwd><kwd>декстрана сульфата натрия</kwd><kwd>DSS колит</kwd><kwd>кроличья животная модель</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Crohn’s disease</kwd><kwd>ulcerative colitis</kwd><kwd>dextran sulfate sodium</kwd><kwd>DSS colitis</kwd><kwd>rabbit animal model</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Pithadia A.B., Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol Rep. 2011; 63(3): 629-42. doi: 10.1016/s1734-1140(11)70575-8.</mixed-citation><mixed-citation xml:lang="en">Pithadia A.B., Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol Rep. 2011; 63(3): 629-42. doi: 10.1016/s1734-1140(11)70575-8.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Valatas V., Vakas M., Kolios G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol. 2013; 305(11): G763-85. doi: 10.1152/ajpgi.00004.2013.</mixed-citation><mixed-citation xml:lang="en">Valatas V., Vakas M., Kolios G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol. 2013; 305(11): G763-85. doi: 10.1152/ajpgi.00004.2013.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bilsborough J., Fiorino M. F., Henkle B. W. Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis. Expert Opin Drug Discov. 2021; 16(5): 567-577. doi: 10.1080/17460441.2021.1851185.</mixed-citation><mixed-citation xml:lang="en">Bilsborough J., Fiorino M. F., Henkle B. W. Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis. Expert Opin Drug Discov. 2021; 16(5): 567-577. doi: 10.1080/17460441.2021.1851185.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Leonardi I., Nicholls F., Atrott K., Cee A., Tewes B., Greinwald R., et al. Oral administration of dextran sodium sulphate induces a caecum-localized colitis in rabbits.Int J Exp Pathol. 2015; 96(3): 151-62. doi: 10.1111/iep.12117.</mixed-citation><mixed-citation xml:lang="en">Leonardi I., Nicholls F., Atrott K., Cee A., Tewes B., Greinwald R., et al. Oral administration of dextran sodium sulphate induces a caecum-localized colitis in rabbits.Int J Exp Pathol. 2015; 96(3): 151-62. doi: 10.1111/iep.12117.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Silva I., Pinto R., Mateus V. Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. J Clin Med. 2019; 8(10): 1574. doi: 10.3390/jcm8101574.</mixed-citation><mixed-citation xml:lang="en">Silva I., Pinto R., Mateus V. Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. J Clin Med. 2019; 8(10): 1574. doi: 10.3390/jcm8101574.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kozik A.J., Nakatsu C. H., Chun H., Jones-Hall Y. L.Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis. PLoS One. 2019; 14(11): e0225079. doi: 10.1371/journal.pone.0225079.</mixed-citation><mixed-citation xml:lang="en">Kozik A.J., Nakatsu C. H., Chun H., Jones-Hall Y. L.Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis. PLoS One. 2019; 14(11): e0225079. doi: 10.1371/journal.pone.0225079.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Maduzia D., Matuszyk A., Ceranowicz D., Warzecha Z., Ceranowicz P., Fyderek K., et al. The influence of pretreatment with ghrelin on the development of acetic-acid-induced colitis in rats. J Physiol Pharmacol. 2015; 66(6): 875-85.</mixed-citation><mixed-citation xml:lang="en">Maduzia D., Matuszyk A., Ceranowicz D., Warzecha Z., Ceranowicz P., Fyderek K., et al. The influence of pretreatment with ghrelin on the development of acetic-acid-induced colitis in rats. J Physiol Pharmacol. 2015; 66(6): 875-85.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wu B., Qiang L., Zhang Y., Fu Y., Zhao M., Lei Z., et al. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling. Cell Mol Immunol. 2022; 19(2): 276-289. doi: 10.1038/s41423-021-00810-9.</mixed-citation><mixed-citation xml:lang="en">Wu B., Qiang L., Zhang Y., Fu Y., Zhao M., Lei Z., et al. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling. Cell Mol Immunol. 2022; 19(2): 276-289. doi: 10.1038/s41423-021-00810-9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Zhang Y., Liu M., Fan C., Feng C., Lu Q., et al. Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis. Acta Pharm Sin B. 2022; 12(1): 228-245. doi: 10.1016/j.apsb.2021.04.007.</mixed-citation><mixed-citation xml:lang="en">Li H., Zhang Y., Liu M., Fan C., Feng C., Lu Q., et al. Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis. Acta Pharm Sin B. 2022; 12(1): 228-245. doi: 10.1016/j.apsb.2021.04.007.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">López-Estévez S., López-Torrellardona J.M., Parera M., Martínez V. Long-lasting visceral hypersensitivity in a model of DSS-induced colitis in rats. Neurogastroenterol Motil. 2022; 34(11): e14441. doi: 10.1111/nmo.14441.</mixed-citation><mixed-citation xml:lang="en">López-Estévez S., López-Torrellardona J.M., Parera M., Martínez V. Long-lasting visceral hypersensitivity in a model of DSS-induced colitis in rats. Neurogastroenterol Motil. 2022; 34(11): e14441. doi: 10.1111/nmo.14441.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hayashi Y., Aoyagi K., Morita I., Yamamoto C., Sakisaka S. Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats. Scand J Gastroenterol. 2009; 44(11): 1323-31. doi: 10.3109/00365520903262414.</mixed-citation><mixed-citation xml:lang="en">Hayashi Y., Aoyagi K., Morita I., Yamamoto C., Sakisaka S. Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats. Scand J Gastroenterol. 2009; 44(11): 1323-31. doi: 10.3109/00365520903262414.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Boussenna A., Joubert-Zakeyh J., Fraisse D., Pereira B., Vasson M. P., Texier O., et al. Felgines C. Dietary Supplementation with a Low Dose of Polyphenol-Rich Grape Pomace Extract Prevents Dextran Sulfate Sodium-Induced Colitis in Rats. J Med Food. 2016; 19(8): 755-8. doi: 10.1089/jmf.2015.0124.</mixed-citation><mixed-citation xml:lang="en">Boussenna A., Joubert-Zakeyh J., Fraisse D., Pereira B., Vasson M. P., Texier O., et al. Felgines C. Dietary Supplementation with a Low Dose of Polyphenol-Rich Grape Pomace Extract Prevents Dextran Sulfate Sodium-Induced Colitis in Rats. J Med Food. 2016; 19(8): 755-8. doi: 10.1089/jmf.2015.0124.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Melgar S., Engström K., Jägervall A., Martinez V. Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice. Stress. 2008; 11(5): 348-62. doi: 10.1080/10253890701820166.</mixed-citation><mixed-citation xml:lang="en">Melgar S., Engström K., Jägervall A., Martinez V. Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice. Stress. 2008; 11(5): 348-62. doi: 10.1080/10253890701820166.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wirtz S., Popp V., Kindermann M., Gerlach K., Weigmann B., Fichtner-Feigl S., Neurath M. F. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017; 12(7): 1295-1309. doi: 10.1038/nprot.2017.044.</mixed-citation><mixed-citation xml:lang="en">Wirtz S., Popp V., Kindermann M., Gerlach K., Weigmann B., Fichtner-Feigl S., Neurath M. F. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017; 12(7): 1295-1309. doi: 10.1038/nprot.2017.044.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Qu S., Fan L., Qi Y., Xu C., Hu Y., Chen S., et al. Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation. Microbiol Spectr. 2021; 9(2): e0073021. doi: 10.1128/Spectrum.00730-21.</mixed-citation><mixed-citation xml:lang="en">Qu S., Fan L., Qi Y., Xu C., Hu Y., Chen S., et al. Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation. Microbiol Spectr. 2021; 9(2): e0073021. doi: 10.1128/Spectrum.00730-21.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gu W., Zhang L., Han T., Huang H., Chen J. Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal Model. J Inflamm Res. 2022; 15: 2631-2647. doi: 10.2147/JIR.S358807.</mixed-citation><mixed-citation xml:lang="en">Gu W., Zhang L., Han T., Huang H., Chen J. Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal Model. J Inflamm Res. 2022; 15: 2631-2647. doi: 10.2147/JIR.S358807.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Rabin B.S., Rogers S. J. A cell-mediated immune model of inflammatory bowel disease in the rabbit. Gastroenterology. 1978; 75(1): 29-33.</mixed-citation><mixed-citation xml:lang="en">Rabin B.S., Rogers S. J. A cell-mediated immune model of inflammatory bowel disease in the rabbit. Gastroenterology. 1978; 75(1): 29-33.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rules of work with laboratory rodents and rabbits GOST 33216-2014. Moscow, Standartinform Publ., 2016. (In Russ.)@@ ГОСТ 33216-2014. Правила работы с лабораторными грызунами и кроликами. - М.: Стандартинформ, 2016.</mixed-citation><mixed-citation xml:lang="en">Rules of work with laboratory rodents and rabbits GOST 33216-2014. Moscow, Standartinform Publ., 2016. (In Russ.)@@ ГОСТ 33216-2014. Правила работы с лабораторными грызунами и кроликами. - М.: Стандартинформ, 2016.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Eichele D.D., Kharbanda K. K. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol. 2017; 23(33): 6016-6029. doi: 10.3748/wjg.v23.i33.6016.</mixed-citation><mixed-citation xml:lang="en">Eichele D.D., Kharbanda K. K. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol. 2017; 23(33): 6016-6029. doi: 10.3748/wjg.v23.i33.6016.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Iwamoto M., Koji T., Makiyama K., Kobayashi N., Nakane P. K. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 1996; 180(2): 152-9. doi: 10.1002/(SICI)1096-9896(199610)180:2&lt;152:: AID-PATH649&gt;3.0.CO;2-Y.</mixed-citation><mixed-citation xml:lang="en">Iwamoto M., Koji T., Makiyama K., Kobayashi N., Nakane P. K. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 1996; 180(2): 152-9. doi: 10.1002/(SICI)1096-9896(199610)180:2&lt;152:: AID-PATH649&gt;3.0.CO;2-Y.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Häger C., Keubler L. M., Biernot S., Dietrich J., Buchheister S., Buettner M., et al. Time to Integrate to Nest Test Evaluation in a Mouse DSS-Colitis Model. PLoS One. 2015; 10(12): e0143824. doi: 10.1371/journal.pone.0143824.</mixed-citation><mixed-citation xml:lang="en">Häger C., Keubler L. M., Biernot S., Dietrich J., Buchheister S., Buettner M., et al. Time to Integrate to Nest Test Evaluation in a Mouse DSS-Colitis Model. PLoS One. 2015; 10(12): e0143824. doi: 10.1371/journal.pone.0143824.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Adamkova P., Hradicka P., Kupcova Skalnikova H., Cizkova V., Vodicka P., Farkasova Iannaccone S., et al. Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease. Vet Sci. 2022; 9(5): 238. doi: 10.3390/vetsci9050238.</mixed-citation><mixed-citation xml:lang="en">Adamkova P., Hradicka P., Kupcova Skalnikova H., Cizkova V., Vodicka P., Farkasova Iannaccone S., et al. Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease. Vet Sci. 2022; 9(5): 238. doi: 10.3390/vetsci9050238.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Plotkin D.V., Reshetnikov M. N., Vinogradova T. I., Zyuzya Yu.R., Gafarov U. O., Zhuravlev V. Yu., et al. Selection of a model object for reproduction of abdominal tuberculosis. Tuberculosis and socially significant diseases. 2021; 3: 18-25. (In Russ.)@@ Плоткин Д. В., Решетников М. Н., Виноградова Т. И., Зюзя Ю. Р., Гафаров У. О., Журавлев В. Ю., и др. Выбор модельного объекта для воспроизведения абдоминального туберкулеза. Туберкулёз и социально значимые заболевания. 2021; (3): 18-25.</mixed-citation><mixed-citation xml:lang="en">Plotkin D.V., Reshetnikov M. N., Vinogradova T. I., Zyuzya Yu.R., Gafarov U. O., Zhuravlev V. Yu., et al. Selection of a model object for reproduction of abdominal tuberculosis. Tuberculosis and socially significant diseases. 2021; 3: 18-25. (In Russ.)@@ Плоткин Д. В., Решетников М. Н., Виноградова Т. И., Зюзя Ю. Р., Гафаров У. О., Журавлев В. Ю., и др. Выбор модельного объекта для воспроизведения абдоминального туберкулеза. Туберкулёз и социально значимые заболевания. 2021; (3): 18-25.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hodgson H.J., Potter B. J., Skinner J., Jewell D. P. Immune-complex mediated colitis in rabbits. An experimental model. Gut. 1978; 19(3): 225-32. doi: 10.1136/gut.19.3.225.</mixed-citation><mixed-citation xml:lang="en">Hodgson H.J., Potter B. J., Skinner J., Jewell D. P. Immune-complex mediated colitis in rabbits. An experimental model. Gut. 1978; 19(3): 225-32. doi: 10.1136/gut.19.3.225.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hotta T., Yoshida N., Yoshikawa T., Sugino S., Kondo M. Lipopolysaccharide-induced colitis in rabbits. Res Exp Med (Berl). 1986; 186(1): 61-9. doi: 10.1007/BF01851834.</mixed-citation><mixed-citation xml:lang="en">Hotta T., Yoshida N., Yoshikawa T., Sugino S., Kondo M. Lipopolysaccharide-induced colitis in rabbits. Res Exp Med (Berl). 1986; 186(1): 61-9. doi: 10.1007/BF01851834.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kawada M., Arihiro A., Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol. 2007; 13(42): 5581-93. doi: 10.3748/wjg.v13.i42.5581.</mixed-citation><mixed-citation xml:lang="en">Kawada M., Arihiro A., Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol. 2007; 13(42): 5581-93. doi: 10.3748/wjg.v13.i42.5581.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Solomon L., Mansor S., Mallon P., Donnelly E., Hoper M., Loughrey M., et al. The dextran sulphate sodium (DSS) model of colitis: an overview.Comp Clin Pathol. 2010; 19: 235-239. doi: 10.1007/s00580-010-0979-4.</mixed-citation><mixed-citation xml:lang="en">Solomon L., Mansor S., Mallon P., Donnelly E., Hoper M., Loughrey M., et al. The dextran sulphate sodium (DSS) model of colitis: an overview.Comp Clin Pathol. 2010; 19: 235-239. doi: 10.1007/s00580-010-0979-4.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
